At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02595 GENFLEET-B
Market Closed 09-25 16:08:14
29.900
-0.180
-0.60%
High30.420
Low29.160
Vol597.60K
Open30.080
D1 Closing30.080
Amplitude4.19%
Mkt Cap11.45B
Tradable Cap10.49B
Total Shares383.00M
T/O17.74M
T/O Rate0.17%
Tradable Shares351.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
GenFleet: Non-Executive Director Tao Sha Announces Resignation Effective 24 September 2026
GENFLEET-B (02595) Share Transfer Worth HK$912 Million, Accounting for 9.11%, with 24.59 Million Shares Moved Out of China Securities Depository and Clearing
GenFleet to Unveil Early Clinical Results for KRAS G12D Inhibitor GFH375 and Pan-RAS Candidate GFH276; Investor Calls and ESMO Late-Breaking Abstract Confirmed
GenFleet Therapeutics (Shanghai) Inc is a China-based company principally engaged in the development of innovative drugs. The Company provides effective new treatment solutions for tumors, autoimmune and inflammatory diseases, covering target discovery, molecular discovery and evaluation, translational science and clinical development, as well as key chemistry manufacturing and controls aspects including formulation research, process development and quality analysis. The Company is mainly engaged in the development of new molecular entities, novel molecular modalities, investigation of molecular process routes and quality standards, and exploration of differentiated clinical development strategies and paths. The Company mainly primarily operates in the domestic and international markets.